drugset / Trial / NCT00926419

Serological Evaluation of Varicella and Hepatitis A Vaccines Using Injector Delivery

NCT00926419

Phase 2/3 Unknown 600 enrolled University of Sao Paulo General Hospital
RandomizedParallel-groupSingle-blindPrevention

Summary

This study aims to assess immunogenicity and safety of nd influence of the delivery system (needle-free injector or syringe with needle) of fractional doses (dose sparing) of two vaccines (Varicella and Hepatitis A vaccines) in children aged 13 to 30 months.

Timeline

Start
2009-06
Primary completion
2009-11
Completion
2010-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Havrix Vaccine 0.1 ml Intramuscular
Subject Havrix Vaccine 0.5 ml Intramuscular
Subject Havrix Vaccine 100 unknown Intramuscular
Subject Varicella vaccine Vaccine 0.1 ml Intravenous
Subject Varicella vaccine Vaccine 0.5 ml Intravenous
Subject Varicella vaccine Vaccine 23.3 unknown Intravenous
Subject Varicella vaccine Vaccine 43.3 unknown Intravenous
Subject Varicella vaccine Vaccine 103.3 unknown Intravenous